Published in PLoS One on March 05, 2015
Disease monitoring in inflammatory bowel disease. World J Gastroenterol (2015) 0.80
Comparisons between myeloperoxidase, lactoferrin, calprotectin and lipocalin-2, as fecal biomarkers of intestinal inflammation in malnourished children. J Transl Sci (2016) 0.78
Fecal Calprotectin in Healthy Children Aged 1-4 Years. PLoS One (2016) 0.75
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first! Ital J Pediatr (2017) 0.75
Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol (2002) 3.20
Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol (1992) 3.09
Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut (2006) 3.00
Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier function, leading to endotoxemia and systemic inflammation. J Nutr (2003) 2.82
Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet (1990) 2.73
A simple method for assessing intestinal inflammation in Crohn's disease. Gut (2000) 2.69
Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem (1997) 2.57
Effects of polymorphonuclear leukocyte transmigration on the barrier function of cultured intestinal epithelial monolayers. J Clin Invest (1987) 2.56
Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol (2007) 2.38
Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2001) 2.33
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis (2008) 2.22
Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol (1999) 2.02
Intestinal permeability in the newborn. Arch Dis Child (1984) 1.94
Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion (1997) 1.92
Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res (2004) 1.88
Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease. Inflamm Bowel Dis (2008) 1.69
Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2001) 1.49
Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg (2010) 1.49
Improved assay for fecal calprotectin. Clin Chim Acta (2000) 1.49
Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr (2002) 1.47
Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis (2004) 1.43
Validation of the pediatric Rome II criteria for functional gastrointestinal disorders using the questionnaire on pediatric gastrointestinal symptoms. J Pediatr Gastroenterol Nutr (2005) 1.38
Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol (2001) 1.29
Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr (2003) 1.23
Intestinal permeability in relation to birth weight and gestational and postnatal age. Arch Dis Child Fetal Neonatal Ed (2003) 1.18
Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Clin Lab (2005) 1.12
Emerging role of calprotectin in gastroenterology. J Gastroenterol Hepatol (2003) 1.12
High faecal calprotectin levels in healthy, exclusively breast-fed infants. Neonatology (2009) 1.11
Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr (2007) 1.11
Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr (2002) 1.08
Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis (2000) 1.08
L1, a major granulocyte protein; isolation of high quantities of its subunits. Scand J Clin Lab Invest (1990) 1.05
Faecal calprotectin in the assessment of Crohn's disease activity. QJM (2005) 1.04
High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed (2004) 1.02
Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. BMC Gastroenterol (2012) 1.02
Fecal calprotectin concentrations are higher in exclusively breastfed infants compared to those who are mixed-fed. Breastfeed Med (2008) 0.98
Fecal calprotectin in healthy term and preterm infants. J Pediatr Gastroenterol Nutr (2004) 0.97
Fecal calprotectin levels are higher in rural than in urban Chinese infants and negatively associated with growth. BMC Pediatr (2012) 0.95
Fecal calprotectin levels are increased in infants with necrotizing enterocolitis. J Matern Fetal Neonatal Med (2012) 0.95
Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey. BMC Pediatr (2011) 0.95
The role of calprotectin in pediatric disease. Biomed Res Int (2013) 0.93
Evaluation of faecal calprotectin as a valuable non-invasive marker in distinguishing gut pathogens in young children with acute gastroenteritis. Acta Paediatr (2010) 0.93
Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am J Clin Pathol (1987) 0.92
Faecal calprotectin in term and preterm neonates. J Pediatr Gastroenterol Nutr (2010) 0.91
Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children. J Pediatr Gastroenterol Nutr (2012) 0.90
Fecal calprotectin excretion in preterm infants during the neonatal period. PLoS One (2010) 0.90
High intestinal IgA associates with reduced risk of IgE-associated allergic diseases. Pediatr Allergy Immunol (2009) 0.86
[Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease]. Rev Esp Enferm Dig (2007) 0.86
Does calprotectin represent a regulatory factor in host defense or a drug target in inflammatory disease? Endocr Metab Immune Disord Drug Targets (2007) 0.85
The effect of intestinal colonization of germ-free pigs with Escherichia coli on calprotectin levels in plasma, intestinal and bronchoalveolar lavages. Immunobiology (2005) 0.84
[Pediatrics. Fecal calprotectin in children: use and interpretation]. Rev Med Suisse (2011) 0.83
Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm. Am J Gastroenterol (2001) 0.82
Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants. J Pediatr Gastroenterol Nutr (2009) 0.81
Fecal calprotectin in Crohn's disease: new family ties. Gastroenterology (2003) 0.80
Comparison of the different kinds of feeding on the level of fecal calprotectin. Early Hum Dev (2014) 0.78
Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood? J Gastroenterol Hepatol (2015) 0.77
Comparison of the different kinds of feeding on the level of fecal calprotectin. Early Hum Dev (2014) 0.78